Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Plos One
|
August 6, 2014
A high-throughput assay for small molecule destabilizers of the KRAS oncoprotein
Joseph Carver, Thomas S Dexheimer, Dennis Hsu, et al.
Cancer Biology & Therapy
|
December 28, 2017
Left atrial abnormality (LAA) as a predictor of ibrutinib-associated atrial fibrillation in patients with chronic lymphocytic leukemia
Anthony R Mato, Suparna Clasen, Peter Pickens, et al.
Analytical Chemistry
|
October 23, 2018
A 2D LC-MS/MS Strategy for Reliable Detection of 10-ppm Level Residual Host Cell Proteins in Therapeutic Antibodies
Feng Yang, Donald E Walker, Jeannine Schoenfelder, et al.
Biotechnology and Bioengineering
|
August 6, 2025
Engineering Chinese Hamster Ovary Cells to Mitigate Polysorbate Degradation in Biotherapeutics
Inn H Yuk, Peggy Ko, Patrick Ahyow, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 25, 2020
High-throughput antibody screening from complex matrices using intact protein electrospray mass spectrometry
William S Sawyer, Neha Srikumar, Joseph Carver, et al.
Biotechnology Progress
|
September 19, 2021
A ribonucleoprotein-based decaplex CRISPR/Cas9 knockout strategy for CHO host engineering
Joseph Carver, Marie Kern, Peggy Ko, et al.
The American Journal of Cardiology
|
July 7, 2024
Symptomatic Heart Failure and Clonal Hematopoiesis-Related Mutations in Patients With Acute Myeloid Leukemia
Yu Kang, Benedicte Lefebvre, Ingrid Marti Pamies, et al.
Biotechnology Journal
|
December 1, 2020
Concurrent transfection of randomized transgene configurations into targeted integration CHO host is an advantageous and cost-effective method for expression of complex molecules
Emily Dong, Cynthia Lam, Danming Tang, et al.
Cardio-Oncology (London, England)
|
November 2, 2024
Cardiotoxicity of venetoclax in patients with acute myeloid leukemia: comparison with anthracyclines
Takeshi Onoue, Andrew H Matthews, Azin Vakilpour, et al.
JAMA Oncology
|
December 30, 2017
Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis
Adam J Waxman, Suparna Clasen, Wei-Ting Hwang, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Plos One
|
August 6, 2014
A high-throughput assay for small molecule destabilizers of the KRAS oncoprotein
Joseph Carver, Thomas S Dexheimer, Dennis Hsu, et al.
Cancer Biology & Therapy
|
December 28, 2017
Left atrial abnormality (LAA) as a predictor of ibrutinib-associated atrial fibrillation in patients with chronic lymphocytic leukemia
Anthony R Mato, Suparna Clasen, Peter Pickens, et al.
Analytical Chemistry
|
October 23, 2018
A 2D LC-MS/MS Strategy for Reliable Detection of 10-ppm Level Residual Host Cell Proteins in Therapeutic Antibodies
Feng Yang, Donald E Walker, Jeannine Schoenfelder, et al.
Biotechnology and Bioengineering
|
August 6, 2025
Engineering Chinese Hamster Ovary Cells to Mitigate Polysorbate Degradation in Biotherapeutics
Inn H Yuk, Peggy Ko, Patrick Ahyow, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 25, 2020
High-throughput antibody screening from complex matrices using intact protein electrospray mass spectrometry
William S Sawyer, Neha Srikumar, Joseph Carver, et al.
Biotechnology Progress
|
September 19, 2021
A ribonucleoprotein-based decaplex CRISPR/Cas9 knockout strategy for CHO host engineering
Joseph Carver, Marie Kern, Peggy Ko, et al.
The American Journal of Cardiology
|
July 7, 2024
Symptomatic Heart Failure and Clonal Hematopoiesis-Related Mutations in Patients With Acute Myeloid Leukemia
Yu Kang, Benedicte Lefebvre, Ingrid Marti Pamies, et al.
Biotechnology Journal
|
December 1, 2020
Concurrent transfection of randomized transgene configurations into targeted integration CHO host is an advantageous and cost-effective method for expression of complex molecules
Emily Dong, Cynthia Lam, Danming Tang, et al.
Cardio-Oncology (London, England)
|
November 2, 2024
Cardiotoxicity of venetoclax in patients with acute myeloid leukemia: comparison with anthracyclines
Takeshi Onoue, Andrew H Matthews, Azin Vakilpour, et al.
JAMA Oncology
|
December 30, 2017
Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis
Adam J Waxman, Suparna Clasen, Wei-Ting Hwang, et al.
Page
of 4